REG - Zotefoams PLC - Notification Of Transactions Of Directors/PDMRs

ZotefoamsAnnouncement

25/03/2026 09:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260325:nRSY0801Ya&default-theme=true

RNS Number : 0801Y  Zotefoams PLC  25 March 2026

Zotefoams plc

(the 'Company')

 

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMR

 

 

The Company announces that on 25 March 2026, Nick Wright, Group Chief
Financial Officer, was granted an award under the Zotefoams Long Term
Incentive Plan 2017 ("LTIP"). The award corresponds to his 2025 LTIP
entitlement, the grant of which was deferred as the Company was in a close
period at the usual grant date.

 

 Directors  Name      Title      Number of LTIP Awards

            N Wright  Group CFO  96,153

 

 

The LTIP award will vest on 23 April 2028 subject to achieving the performance
criteria detailed in the Company's Annual Report 2024. The vesting date aligns
with the vesting timetable for other participants' 2025 LTIP awards. A holding
period of two years following the vesting date will apply.

 

The Notification of Dealing Form for each Director/PDMR can be found below.

 

This announcement is made in accordance with the requirements of Article 19 of
the UK Market Abuse Regulation.

 

Emma Woollard

Company Secretary

Zotefoams plc

020 8051 2770

 

Enquiries:

 

 Zotefoams plc            IFC Advisory (Financial PR & IR)
 Ronan Cox, Group CEO     Graham Herring

 Nick Wright, Group CFO   Tim Metcalfe

                          Zach Cohen

 +44 (0) 208 664 1600     +44 (0) 203 934 6630

About Zotefoams plc

 

Zotefoams plc (LSE - ZTF) is a world leader in high-performance foam
technology delivering optimal material solutions for the benefit of society.
Utilising a variety of unique manufacturing processes, including
environmentally friendly nitrogen expansion for lightweight
AZOTE(®) polyolefin and ZOTEK(®) high-performance foams, Zotefoams sells
to diverse markets worldwide. Zotefoams uses its own cellular materials to
manufacture T-FIT(®) advanced insulation for demanding industrial markets.

Zotefoams is headquartered in London, UK, with manufacturing sites
in Croydon, UK, Kentucky, USA and Brzeg, Poland (foam
manufacture), Oklahoma, USA (foam products manufacture and conversion),
Anglesola and Burgos, Spain (foam manufacture) and Jiangsu
Province, China (T-FIT).

www.zotefoams.com (http://www.zotefoams.com/)

AZOTE(®), ZOTEK(®), ReZorce(®) and T-FIT(®) are registered trademarks
of Zotefoams plc

DEALING NOTIFICATION FORM

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY
ASSOCIATED PERSONS

 

 1.  Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name: Nick Wright
 2.  Reason for the notification
 a)  Position/status: Group CFO
 b)  Initial notification/Amendment: Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name:   Zotefoams plc
 b)  LEI: 213800B6P256B5XN8D32
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument:

     Ordinary shares of 5 pence each

     Identification code: GB0009896605
 b)  Nature of the transaction: Award of performance shares under the Long-Term
     Incentive Plan with a holding period of 2 years post vesting date
 c)  Price(s) and volume(s):

Price(s)  Volume(s)
     £0.00     96,153
 d)  Aggregated information:

     n/a - single transaction
 e)  Date of the transaction: 25 March 2026
 f)  Place of the transaction: XLON

d)

Aggregated information:

n/a - single transaction

e)

Date of the transaction: 25 March 2026

f)

Place of the transaction: XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHJAMLTMTJTMIF



            Copyright 2019 Regulatory News Service, all rights reserved